Pancreas regeneration: pancreatic progenitors and their niche

Summary

Type 1 diabetes is caused by an autoimmune destruction of pancreatic β cells. These cells are the source of insulin, a hormone required for the regulation of blood glucose levels. One approach to recovering glucose homeostasis would be to induce restoration of β-cell mass, either by replacement with exogenous cells or by regeneration from endogenous progenitors, but the existence of such progenitors is still controversial. Rovira’s group is focused in the role of ductal cells as pancreatic progenitors in order to develop new therapies for diabetes treatment. On the other hand the lab is also studying the niche required for pancreatic progenitor maintenance.

< class="pp-fancy-heading-title">22

Publications

Pancreas-regeneration-pancreatic-progenitors-and-their-niche
Meritxell-Rovira22

Rovira Clusellas, Meritxell

mrovira@idibell.cat

Principal investigators

Meritxell-Rovira22

Rovira Clusellas, Meritxell

mrovira@idibell.cat

RELATED LINKS

@LabRovira

ORCID

Google Scholar

Team

Group leaders
Group leaders
  • Rovira Clusellas, Meritxell
Postdoctoral researchers
Investigadors/es predoctorals
Scientific support

Related news

< class="pp-content-grid-title pp-post-title" itemprop="headline"> Researchers describe a cellular map of the pancreas that will help design better treatments against pancreatic cancer and diabetes
By comunicacio | 02/09/2024
< class="pp-content-grid-title pp-post-title" itemprop="headline"> A study describes how insulinomas, a rare type of pancreatic beta cell tumour, form
By comunicacio | 18/07/2024
< class="pp-content-grid-title pp-post-title" itemprop="headline"> Dr. Meritxell Rovira, awarded with the “CRIS de Excelencia” Program to study pancreatic cancer
By comunicacio | 18/04/2024
< class="pp-content-grid-title pp-post-title" itemprop="headline"> IDIBELL receives 25.907€ thanks to the donations of Bonpreu and Esclat customers
By comunicacio | 12/12/2023
< class="pp-content-grid-title pp-post-title" itemprop="headline"> The ”la Caixa” Foundation promotes a promising study against pancreatic cancer
By comunicacio | 24/11/2023
< class="pp-content-grid-title pp-post-title" itemprop="headline"> Bonpreu and Esclat join the fight against diabetes with a fundraising campaign in favor of IDIBELL
By comunicacio | 07/11/2023
< class="pp-content-grid-title pp-post-title" itemprop="headline"> A study describes a new way to generate insulin-producing cells
By comunicacio | 22/06/2022
< class="pp-content-grid-title pp-post-title" itemprop="headline"> Begins the exchange program between IDIBELL and SZBL
By comunicacio | 06/05/2022
< class="pp-content-grid-title pp-post-title" itemprop="headline"> We close a 2021 full of science!
By comunicacio | 30/12/2021
< class="pp-content-grid-title pp-post-title" itemprop="headline"> Pancreatic beta-cell boost in mice paves way for future diabetes treatments
By comunicacio | 11/08/2021
Scroll to Top